SunTrust Downgrades Zafgen (ZFGN) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/3/2026
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Goldman's Garrett sees investors dialing back tech exposure into H2
- AI chip winners may face tougher road ahead as hyperscalers catch up: JPM
- Oil gains on short-covering buys ahead of US holiday
- Rivian stock jumps 5% on raised delivery outlook
- Analysis-Excommunications show a Pope Leo unafraid of making firm decisions
- Dow jumps to record closing high after soft US jobs data, Nasdaq down with chip shares
- Canaccord Starts Infleqtion, Inc (INFQ) at Buy
- Jersey Mike's Subs files for IPO on NYSE under ticker JMKE
- AXT-Tongmei signs 3-year wafer supply deal with Coherent
Leerink Partners Downgrades Zafgen (ZFGN) to Market Perform
December 3, 2015 11:02 AM ESTLeerink Partners downgraded Zafgen (NASDAQ: ZFGN) from Outperform to Market Perform with a price target of $7.00 (from $11.00) after further lowering probability of success for beloranib to 30% (from 40% previously) in our SOTP DCF analysis since the threshold for justifying risk-benefit has considerably been increased w/... More
